Literature DB >> 11978847

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Anissa Abi-Dargham1, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum, Jack M Gorman, Marc Laruelle.   

Abstract

Studies in nonhuman primates documented that appropriate stimulation of dopamine (DA) D1 receptors in the dorsolateral prefrontal cortex (DLPFC) is critical for working memory processing. The defective ability of patients with schizophrenia at working memory tasks is a core feature of this illness. It has been postulated that this impairment relates to a deficiency in mesocortical DA function. In this study, D1 receptor availability was measured with positron emission tomography and the selective D1 receptor antagonist [11C]NNC 112 in 16 patients with schizophrenia (seven drug-naive and nine drug-free patients) and 16 matched healthy controls. [11C]NNC 112 binding potential (BP) was significantly elevated in the DLPFC of patients with schizophrenia (1.63 +/- 0.39 ml/gm) compared with control subjects (1.27 +/- 0.44 ml/gm; p = 0.02). In patients with schizophrenia, increased DLPFC [11C]NNC 112 BP was a strong predictor of poor performance at the n-back task, a test of working memory. These findings confirm that alteration of DLPFC D1 receptor transmission is involved in working memory deficits presented by patients with schizophrenia. Increased D1 receptor availability observed in patients with schizophrenia might represent a compensatory (but ineffective) upregulation secondary to sustained deficiency in mesocortical DA function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978847      PMCID: PMC6758376          DOI: 20026302

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  94 in total

1.  Rapid automated algorithm for aligning and reslicing PET images.

Authors:  R P Woods; S R Cherry; J C Mazziotta
Journal:  J Comput Assist Tomogr       Date:  1992 Jul-Aug       Impact factor: 1.826

2.  Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging.

Authors:  A A Stevens; P S Goldman-Rakic; J C Gore; R K Fulbright; B E Wexler
Journal:  Arch Gen Psychiatry       Date:  1998-12

3.  Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys.

Authors:  J X Cai; A F Arnsten
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

4.  Activation of the prefrontal cortex in a nonspatial working memory task with functional MRI.

Authors:  J D Cohen; S D Forman; T S Braver; B J Casey; D Servan-Schreiber; D C Noll
Journal:  Hum Brain Mapp       Date:  1994       Impact factor: 5.038

5.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

6.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI.

Authors:  D S Manoach; D Z Press; V Thangaraj; M M Searl; D C Goff; E Halpern; C B Saper; S Warach
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

7.  Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.

Authors:  M Laruelle; C van Dyck; A Abi-Dargham; Y Zea-Ponce; S S Zoghbi; D S Charney; R M Baldwin; P B Hoffer; H F Kung; R B Innis
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

8.  The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results.

Authors:  D L Braff; R Heaton; J Kuck; M Cullum; J Moranville; I Grant; S Zisook
Journal:  Arch Gen Psychiatry       Date:  1991-10

9.  Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm.

Authors:  K Fleming; T E Goldberg; J M Gold; D R Weinberger
Journal:  Psychiatry Res       Date:  1995-03-27       Impact factor: 3.222

10.  Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task.

Authors:  G McCarthy; A M Blamire; A Puce; A C Nobre; G Bloch; F Hyder; P Goldman-Rakic; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  232 in total

Review 1.  Dopaminergic dysfunction in schizophrenia: salience attribution revisited.

Authors:  Andreas Heinz; Florian Schlagenhauf
Journal:  Schizophr Bull       Date:  2010-05-07       Impact factor: 9.306

Review 2.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 3.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 4.  [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Authors:  Andreas Heinz; Dieter F Braus; Berenice Romero; Jürgen Gallinat; Imke Puls; Georg Juckel; Daniel R Weinberger
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

Review 5.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

6.  Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors.

Authors:  Yan-You Huang; Eleanor Simpson; Christoph Kellendonk; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

7.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

8.  The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning.

Authors:  M Victoria Puig; Earl K Miller
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

9.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

Review 10.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.